Who Responds To The Responders?

Who Responds To The Responders?

As I thought it might, my last post about social media stirred quite a bit of discussion. As such, I thought it would be useful to perhaps dedicate another post as a means of both clarifying my position, and providing some counter-points to the various responses that have been generated around the web. To recap, my original post wasn’t meant to suggest that pharma should completely abandon social media, but rather that the interest in social engagements is over-calibrated when weighed against the potential business impact for a given brand….

Social Media Supplement, Issue 4 – More Facebook Insights

Social Media Supplement, Issue 4 – More Facebook Insights

This issue includes several interesting studies surrounding Facebook’s News Feed as well as Likes for brands, as well as e-commerce. On to this week’s news!  Did we miss something?  Feel free to DM me during the week and we’ll review submissions for the next post! Click here to catch up on past issues. Facebook News Feed Results Cracked In an experiment by The Daily Beast believes it has cracked the code as to how the Facebook News Feed works.  Some of this is common knowledge, but there are a few outcomes that are…

Social Media Supplement, Issue 3 — Microsoft Making Plays

Social Media Supplement, Issue 3 — Microsoft Making Plays

Some of the hot items in the news this week have been at Microsoft, with their new features in Bing and with their new mobile OS.  Check out articles below for this week’s round-up of social media and technology news. If you want to catch up on past issues, go here. Did we miss something?  Feel free to DM me during the week and we’ll review submissions for the next post!  Now, let’s get to the good stuff… Twitter About to Start Raking it in [Interview] Twitter had a changing…

Social Media Supplement, Issue 2 — A Busy Week for Facebook

Social Media Supplement, Issue 2 — A Busy Week for Facebook

Since this is only the second issue of this feature here on Dose of Digital, here’s just a quick reminder of what it’s all about. If you know all of this, just skip down to the good stuff. You can find Issue 1 here. This regular series will be a review of the biggest stories in social media and digital technology over the previous week. It’s not pharma or healthcare specific, so this should be helpful to keep you abreast of everything else out there if you don’t get the…